Citation 68786

KASHMAN,Y: GUSTAFSON,KR: FULLER,RW: CARDELLINA II,JH: MC MAHON,JB: CURRENS,MJ: BUCKHEIT JR,RW: HUGHES,SH: CRAGG,GM: BOYD,MR:. (1992). THE CALANOLIDES, A NOVEL HIV-INHIBITORY CLASS OF COUMARIN DRIVATIVES FROM THE TROPICAL RAINFOREST TREE, CALOPHYLLUM LANIGERUM.. 35(15)

Citation Details

TitleTHE CALANOLIDES, A NOVEL HIV-INHIBITORY CLASS OF COUMARIN DRIVATIVES FROM THE TROPICAL RAINFOREST TREE, CALOPHYLLUM LANIGERUM.
AuthorsKASHMAN,Y: GUSTAFSON,KR: FULLER,RW: CARDELLINA II,JH: MC MAHON,JB: CURRENS,MJ: BUCKHEIT JR,RW: HUGHES,SH: CRAGG,GM: BOYD,MR:
Year1992
Volume35
Issue15

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Calophyllum lanigerum (CLUSIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
ACTIVE
3Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE A
None
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CALANOLIDE A
ACTIVE
5
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE A
ACTIVE
6
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
CALANOLIDE A
ACTIVE
7
REVERSE TRANSCRIPTASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
CALANOLIDE A
INACTIVE
8Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
COSTATOLIDE,(-):
None
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COSTATOLIDE,(-):
ACTIVE
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COSTATOLIDE,(-):
ACTIVE
11Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE D
None
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE D
ACTIVE
13Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE A,12-ACETOXY:
None
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CALANOLIDE A,12-ACETOXY:
ACTIVE
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE A,12-ACETOXY:
ACTIVE
16Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE A,12-METHOXY:
None
17
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE A,12-METHOXY:
ACTIVE
18Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE B,12-METHOXY:
None
19
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE B,12-METHOXY:
ACTIVE
20Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE C
None
21
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE C
ACTIVE
22Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALANOLIDE E
None
23
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CALANOLIDE E
ACTIVE
Show SPARQL Queries (1)